Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05282394 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Newborn Abdominal Massage to Prevent Hyperbilirubinemia

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 22, 2026 (before its estimated September 30, 2026 completion). Its status may not reflect the trial's current state.
Trial flagged as At Risk
Primary completion moved at least 3 months later Jun 30, 2026 → Sep 30, 2026
See other at-risk trials from University of California, Davis

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Jun 30, 2026 to Sep 30, 2026
    • Eligibility criteria expanded, about 7 words
    • Secondary endpoints: details revised at 1 of 7 entries
  2. Primary and study completion dates: Jun 2025 to Jun 30, 2026v10
  3. Primary and study completion dates: Apr 2025 to Jun 2025v9
  4. Trial status: Recruiting to Active, Not Recruiting
    • Primary and study completion dates: Dec 31, 2024 to Apr 2025
    • Site details revised
    v8
  5. Primary and study completion dates: Sep 30, 2024 to Dec 31, 2024v7
Show 5 earlier versionsHide 5 earlier versions
  1. Primary completion date: Feb 28, 2024 to Sep 30, 2024v6
  2. Primary completion date: Feb 28, 2023 to Feb 28, 2024v5
  3. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Eligibility criteria revised
    v4
  4. Start date: May 7, 2022 to Aug 1, 2022v3
  5. Start date: Mar 7, 2022 to May 7, 2022v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The proposed study will incorporate an intervention previously un-studied in the US healthcare setting for prevention of hyperbilirubinemia
Trial Details
NCT Number NCT05282394
Lead Sponsor University of California, Davis
Collaborators: National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Conditions
(from sponsor)		 Newborn Jaundice
Related terms Jaundice, Neonatal
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov